[1] |
ZHONG Wei, SHI Shuxia, QIN Qinyue, YU Guo.
Measurement tools and rationality evaluation of clinical research coordinator's work ability and workload
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 937-947.
|
[2] |
SHI Gexin, CHONG Rui, HE Kun, WU Haitang, ZHOU Yu, DUN Zhongjun, WEN Qing, ZHANG Jiguo, ZHANG Rong.
A fully replicated crossover bioequivalence study of mycophenolate mofetil capsules in Chinese healthy male subjects under fasting and fed conditions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1255-1263.
|
[3] |
FANG Qiujue, WANG Zhaojun, YUAN Wei, DING Shu, WANG Zhongqun.
Correlation between soluble ST2 and coronary artery complex lesions and their severity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 278-284.
|
[4] |
WANG Xiaqin, HE Fei, WANG Tong, HU Zhangle.
Admission Neutrophil-to-lymphocyte ratio predicts coronary lesion complexity and clinical risk in patients with unstable angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 296-300.
|
[5] |
ZHONG Zhiyong, TAO Jiong, WANG Xianglan, HAN Hongying, LI Lingjiang.
Treatment of major depression with short-term MECT in addition to antidepressants: its effects on clinical efficacy and cognitive function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 179-183.
|
[6] |
WANG Jue,QIAO Qing, CHENG Maoliang, LI Wanchun, WANG Yipin, YING Wei.
Effects of Ginkgo biloba tablet on MPA, CD11b and MCP-1 levels in patients with unstable angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1421-1425.
|
[7] |
XU Maodi,WU Zijing, XIE Haitang.
Advances in bioequivalence of narrow therapeutic index drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1201-1206.
|
[8] |
XIE Xiang-zhi, XU Guo-lei, WU Xin-fang, CHEN Jun.
Clinical observation of stable angina pectoris with the treatment of Wumei Wan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 83-85.
|
[9] |
ZHONG Zhi-yong, ZHANG Ming, WANG Ji-hui, WU Xiao-li.
A retrospective study of risperidone oral solution versus olanzapine tablets in treating brain organic mental disorders
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1047-1051.
|
[10] |
HUO Yong-jia.
Effects of fluvastatin on exercise-induced myocardial ischemia in patients with stable exertional angina pectoris and hypercholesterolemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(2): 200-203.
|
[11] |
PU Jiang-chen, SHEN Li-hua.
Effects and comparison of promoting the blood flow of Chinese formulated products on endothelial function in chronic stable angina
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 331-334.
|
[12] |
MA Li-yuan, WANG Wen.
Quality control of large scale clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(1): 106-109.
|
[13] |
SHI Hai-xia, HUANG Ji-han, LI Qing-hai, BIAN Ka.
Effects of Quyuningxin pill to unstable angina pectoris efficacy and serum C-reactive protein
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(5): 582-585.
|
[14] |
GAO Wen-jun, LIU Wen-jie, KE Yong-sheng.
Clinical evidence-based study on new-generation drug-eluting stent: everolimus-eluting stents (Xience V)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(5): 591-595.
|
[15] |
LV Ying-hua, XU Ling, YANG Juan, HE Ying-chun, LIU Hong-xia, SUN Rui-yuan, ZHENG Qingshan.
Study of mathematical models of scales for evaluating efficacy in symptomatology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(7): 808-813.
|